Second Opinion® Pediatric

Pearl, Inc.'s "Second Opinion® Pediatric" is a computer-aided detection (CADe) software designed to assist dental health professionals in identifying caries on radiographs for patients aged 4 years and older. The device employs machine learning and computer vision to process dental images and highlight areas of suspected caries, with clinical studies demonstrating high accuracy and sensitivity.

Pearl, Inc. has obtained clearance to market its "Second Opinion® Pediatric" software device, determined to be substantially equivalent to an existing product. This computer-aided detection (CADe) software is specifically engineered to aid dental health professionals in identifying caries, or cavities, on both bitewing and periapical radiographs for patients aged 4 years and older, encompassing those with primary or permanent dentition. The "Second Opinion® Pediatric" system leverages machine learning and computer vision technologies to analyze dental images and visually indicate areas suspected of caries, operating as a software-only solution. Its key differentiation from its predicate device is the inclusion of a younger patient population. Clinical studies have demonstrated the device's efficacy, showing high accuracy and sensitivity in caries detection, thereby affirming its safety and effectiveness for its stated purpose, although users are cautioned against exclusive reliance on its outputs for clinical decision-making due to potential false detections.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific machine learning algorithms and computer vision techniques are employed by the "Second Opinion® Pediatric" device for caries detection?; How do the accuracy and sensitivity metrics of the "Second Opinion® Pediatric" compare to the predicate device, particularly in the expanded pediatric patient population?; What are the reported false positive and false negative rates of the software, and what are the clinical implications of these errors in a pediatric dental setting?; Were the clinical studies supporting the device's effectiveness conducted independently, and what was the demographic breakdown and caries prevalence of the patient cohort?; What specific training and integration protocols are recommended for dental professionals to effectively use this CADe software and mitigate risks associated with potential false detections?